Brandt, I. A. G., Vestergaard, P.
, Harsløf, T., Juhl, C. B., Rasmussen, N. H. H. & Frost, M. (2025).
Association between Muscle Status and Bone Size, Density, and Strength in Type 1 Diabetes: A Cross-sectional Study.
Journal of Clinical Endocrinology and Metabolism,
110(12), e4011-e4022.
https://doi.org/10.1210/clinem/dgaf245Brandt, I. A. G.
, Viggers, R., Harsløf, T., Frost, M.
& Vestergaard, P. (2025).
Bone properties in persons with type 1 diabetes and healthy controls - A cross-sectional study.
Bone,
190, Article 117306.
https://doi.org/10.1016/j.bone.2024.117306Brantlov, S., Ward, L. C.
, Isidor, S., Hvas, C. L., Rud, C. L. & Jødal, L. (2025).
Cell Membrane Capacitance (Cm) Measured by Bioimpedance Spectroscopy (BIS): A Narrative Review of Its Clinical Relevance and Biomarker Potential.
Sensors,
25(14), Article 4362.
https://doi.org/10.3390/s25144362
Brask-Thomsen, P. K., Itani, M.
, Karlsson, P., Kristensen, A. G., Krøigård, T.
, Jensen, T. S., Tankisi, H., Sindrup, S. H.
, Finnerup, N. B. & Gylfadottir, S. S. (2025).
Neuropathic pain in diabetic polyneuropathy: a 5-year prospective study.
Pain. Advance online publication.
https://doi.org/10.1097/j.pain.0000000000003649
Brock, C., Andersen, H., Alibegovic, A. C.
, Andersen, S. T., Andreasen, L. J.
, Charles, M. H., Christensen, D. H., Drewes, A. M., Gall, M. A.
, Gylfadottir, S. S., Hansen, C. S., Hecquet, S. K.
, Jensen, T. S., Karlsson, P., Knudsen, L. B., Lobato, C. B., Kufaishi, H., Maalmi, H., Mizrak, H. I. ... Pop-Busui, R. (2025).
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.
Diabetes Research and Clinical Practice,
221, Article 112010.
https://doi.org/10.1016/j.diabres.2025.112010,
https://doi.org/10.1016/j.diabres.2025.112010
Brorson, J., Lin, L., Wang, J., Bæk, A., Billeskov, T. B., Thybo, F. F., Just, J., Haskó, J., Ravn, C., Hansen, R. L., Bue, M., Jørgensen, J. O. L., Luo, Y., Jessen, N. & Farup, J. (2025).
Complementing muscle regeneration-fibro-adipogenic progenitor and macrophage-mediated repair of elderly human skeletal muscle.
Nature Communications,
16(1), Article 5233.
https://doi.org/10.1038/s41467-025-60627-2
Brøsen, J. M. B., Agesen, R. M., Alibegovic, A. C., Andersen, H. U., Beck-Nielsen, H., Gustenhoff, P.
, Hansen, T. K., Hedetoft, C., Jensen, T. J., Juhl, C. B., Stolberg, C. R., Lerche, S. S., Nørgaard, K., Parving, H. H., Tarnow, L., Thorsteinsson, B. & Pedersen-Bjergaard, U. (2025).
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia.
Journal of Diabetes Science and Technology,
19(2), 390-399.
https://doi.org/10.1177/19322968231197423Brum, W. S., Montoliu-Gaya, L., Brinkmalm, G., Piotrowska, D., Camporesi, E., Jäger, C., Isaksson, H. S., Martin, S., Kindberg, J., Lantero-Rodriguez, J., Ferrari-Souza, J. P., Moscoso, A., Benedet, A. L., Janelidze, S., Gobom, J., Zetterberg, H., Hansson, O., Zimmer, E. R., Ashton, N. J. ... Blennow, K. (2025).
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study.
Acta Neuropathologica,
150(1), Article 36.
https://doi.org/10.1007/s00401-025-02930-2Cardoso, L. M.
, Rolighed, L., Amrein, K., Pilz, S.
, Underbjerg, L., Pretorius, M., Cetani, F., Zahn, A., Almquist, M., Makay, O., Marcocci, C.
, Rejnmark, L., Siggelkow, H., Tsourdi, E., Kamenický, P. & Bollerslev, J. (2025).
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders.
European Journal of Endocrinology,
193(6), R65-R88.
https://doi.org/10.1093/ejendo/lvaf204Carlsson, M., Frank, E., Màrmol, J. M., Ali, M. S., Raun, S. H., Battey, E., Andersen, N. R., Irazoki, A., Lund, C., Henríquez-Olguin, C., Højfeldt, M. K., Blomquist, P.
, Bromer, F. D., Mocciaro, G., Lodber, A.
, Folsted Andersen, C. B., Eijken, M., Fritzen, A. M., Knudsen, J. R. ... Sylow, L. (2025).
Activin receptor type IIA/IIB blockade increases muscle mass and strength, but compromises glycemic control in mice: Activin receptor inhibition increases muscle mass and strength, but compromises glycemic control.
Molecular Metabolism,
102, Article 102261.
https://doi.org/10.1016/j.molmet.2025.102261